Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology TrendingStockAlerts · Dec 18, 2025
Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Induction Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on December 16, 2025 TrendingStockAlerts · Dec 17, 2025
Ascletis Announces Positive Topline Results from U.S. Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor TrendingStockAlerts · Dec 16, 2025
Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout TrendingStockAlerts · Dec 15, 2025
NanOlogy Unveils Drug Development Program for Rare Pediatric Brainstem Tumor TrendingStockAlerts · Dec 14, 2025
mAbxience and HP drive the use of artificial intelligence in biomanufacturing and biosimilar development TrendingStockAlerts · Dec 5, 2025
New Data Presented at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF TrendingStockAlerts · Dec 4, 2025
CABIO Showcases Life-Stage Nutrition Innovation at Fi Europe 2025 Paris as the New Global Headquarter Opens TrendingStockAlerts · Dec 3, 2025
ScreenPoint Medical Showcases Transpara Breast AI Suite at RSNA 2025 TrendingStockAlerts · Dec 2, 2025
BioDlink Showcases Europe-China CMC Collaboration Amid Developmental Breakthrough TrendingStockAlerts · Dec 1, 2025
